The Academy of Medical Science’s FORUM brings together senior leaders from across the life sciences sectors to accelerate progress through collaboration and innovation. Such an independent platform and wide-reaching network, with its ability to convene individuals from universities, medical schools, biotech, pharma, regulators, healthcare providers, professional bodies, funders and others, is not replicated in any other organisation.
The Academy and the Association of the British Pharmaceutical Industry are holding a joint workshop on 3 July to explore endpoints in clinical research, using oncology as an exemplar. It will be co-chaired by Dr David Montgomery, Pfizer, and Professor Tim Elliott FMedSci, University of Southampton.
The workshop will bring together key stakeholders including industry, academia, regulators, patients, clinicians, funders and commissioners, amongst others, to discuss and identify ways to overcome the challenges associated with selecting study endpoints in oncology, and consider those outcomes that are important for clinical trial measures to be ‘fit for purpose’, now and in the future.
The workshop will provide opportunities to debate different perspectives in an interactive setting (patients, industry, regulators, clinicians, payers, academics, statisticians) and address key questions around the relevance, utility and acceptability of different endpoints across different stakeholders. Please note that this event is by invitation only, and for further details please contact firstname.lastname@example.org.